🦠 Melanoma - Feb 2026

• Personalized mRNA vaccine shows durable reduction in melanoma recurrence
• HOXD13 regulates angiogenesis and immune evasion in melanoma
• Pepyrus boosts sensitivity in HLA-bound neoantigen discovery
• SITC defines consensus criteria for ICI resistance
• Vibostolimab adds no benefit over pembrolizumab alone in melanoma
• Pathologic response assessment shows high reproducibility across tumor types

https://pir.sh/RbZ1DNrajK

#Melanoma #Immunotherapy #Oncology

Melanoma Research Summary February 2026 - Summarized Science

Summary of key Melanoma publications highlighting major findings, clinical relevance, and emerging research trends.